Asahi Life Asset Management CO. LTD. Acquires New Shares in Oak Street Health, Inc. (NYSE:OSH)

Asahi Life Asset Management CO. LTD. bought a new position in Oak Street Health, Inc. (NYSE:OSH) in the second quarter, HoldingsChannel reports. The fund bought 3,120 shares of the company’s stock, valued at approximately $183,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Capital International Investors boosted its holdings in shares of Oak Street Health by 114.0% during the 1st quarter. Capital International Investors now owns 7,597,730 shares of the company’s stock valued at $412,329,000 after acquiring an additional 4,046,725 shares during the last quarter. BlackRock Inc. lifted its position in Oak Street Health by 27.2% during the first quarter. BlackRock Inc. now owns 4,860,912 shares of the company’s stock valued at $263,803,000 after purchasing an additional 1,039,442 shares during the period. Millennium Management LLC boosted its holdings in Oak Street Health by 7.9% in the first quarter. Millennium Management LLC now owns 2,205,420 shares of the company’s stock worth $119,688,000 after purchasing an additional 162,015 shares during the last quarter. Gilder Gagnon Howe & Co. LLC grew its position in Oak Street Health by 0.3% in the 1st quarter. Gilder Gagnon Howe & Co. LLC now owns 1,982,987 shares of the company’s stock worth $107,617,000 after purchasing an additional 6,252 shares during the period. Finally, Price T Rowe Associates Inc. MD raised its stake in Oak Street Health by 11.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,636,570 shares of the company’s stock valued at $88,817,000 after buying an additional 165,236 shares during the last quarter. Institutional investors and hedge funds own 79.41% of the company’s stock.

In other news, CEO Michael T. Pykosz sold 185,000 shares of Oak Street Health stock in a transaction that occurred on Tuesday, July 20th. The shares were sold at an average price of $57.63, for a total transaction of $10,661,550.00. Following the sale, the chief executive officer now owns 8,087,240 shares in the company, valued at $466,067,641.20. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, COO Geoffrey M. Price sold 50,000 shares of Oak Street Health stock in a transaction that occurred on Tuesday, June 22nd. The shares were sold at an average price of $59.33, for a total transaction of $2,966,500.00. Following the sale, the chief operating officer now owns 3,817,389 shares in the company, valued at approximately $226,485,689.37. The disclosure for this sale can be found here. In the last quarter, insiders have sold 884,830 shares of company stock worth $49,604,633. Company insiders own 10.10% of the company’s stock.

Several brokerages recently commented on OSH. Canaccord Genuity cut their price objective on Oak Street Health from $67.00 to $61.00 and set a “buy” rating for the company in a report on Wednesday, August 11th. Cowen started coverage on Oak Street Health in a research note on Thursday, September 9th. They set an “outperform” rating and a $61.00 price target for the company. Sanford C. Bernstein began coverage on shares of Oak Street Health in a research note on Friday, May 21st. They issued an “outperform” rating and a $79.00 price objective on the stock. Robert W. Baird began coverage on shares of Oak Street Health in a report on Tuesday, September 7th. They issued an “outperform” rating and a $60.00 price objective on the stock. Finally, Zacks Investment Research raised shares of Oak Street Health from a “sell” rating to a “hold” rating in a report on Tuesday, May 18th. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $67.80.

Shares of NYSE:OSH opened at $51.68 on Wednesday. The company has a debt-to-equity ratio of 4.07, a current ratio of 3.40 and a quick ratio of 3.40. Oak Street Health, Inc. has a 1-year low of $37.41 and a 1-year high of $66.31. The company has a market capitalization of $12.45 billion and a P/E ratio of -40.38. The firm’s 50 day simple moving average is $54.57 and its two-hundred day simple moving average is $56.94.

Oak Street Health (NYSE:OSH) last issued its quarterly earnings results on Monday, August 9th. The company reported ($0.44) earnings per share for the quarter, missing the consensus estimate of ($0.36) by ($0.08). Oak Street Health had a negative net margin of 27.56% and a negative return on equity of 88.34%. The firm had revenue of $353.10 million for the quarter, compared to analysts’ expectations of $318.09 million. The firm’s quarterly revenue was up 64.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Oak Street Health, Inc. will post -1.78 earnings per share for the current fiscal year.

About Oak Street Health

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.

Recommended Story: What is the S&P 500 Index?

Want to see what other hedge funds are holding OSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oak Street Health, Inc. (NYSE:OSH).

Institutional Ownership by Quarter for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.